Lunai Bioworks Inc. Stock Issued During Period, Shares, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lunai Bioworks Inc. stock issued during period, shares, issued for services for the quarter ending 2022-03-31 was 60.00K shares.
- Lunai Bioworks Inc. stock issued during period, shares, issued for services for the quarter ending 2021-12-31 was 60.00K shares, a 300.00% increase year-over-year.
- Lunai Bioworks Inc. stock issued during period, shares, issued for services for the quarter ending 2021-03-31 was 0.00 shares.
- Lunai Bioworks Inc. stock issued during period, shares, issued for services for the quarter ending 2020-12-31 was 15.00K shares, a 50.00% decline year-over-year.
| Period end | Stock Issued During Period, Shares, Issued for Services 3 month | Stock Issued During Period, Shares, Issued for Services 12 month |
|---|---|---|
| 2022-03-31 | 60.00K shares 10-Q · filed 2022-05-13 | |
| 2021-12-31 | 60.00K shares 10-Q · filed 2022-02-14 | |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 15.00K shares 10-Q · filed 2021-02-16 | |
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-17 | |
| 2019-12-31 | 30.00K shares 10-Q · filed 2021-02-16 | |
| 2019-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | |
| 2018-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-10 | |
| 2018-09-30 | 10.00K shares 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |